aTyr Pharma (LIFE) Shares Fall Following Common Stock Offering News

aTyr Pharma, Inc. (Nasdaq: LIFE) today made an announcement on its commencement of a public offering of shares of its common stock, with a 30-day option for underwriters to purchase additional shares of its common stock. The offering, for which Piper Sandler and RBC Capital Markets are acting as joint book-running managers, is expected to price the shares between $8.00 and $8.25, early reports indicated. The total number of shares being was unknown at this time.

The company’s shares closed with a 5.33% loss today and were trading more than 1.5% lower after-hours.

The stock has seen recent gains after the company announced positive results from its Phase 1b/2a data for ATYR1923 in pulmonary sarcoidosis patients on Monday.

You May Also Be Interested In

• CopperTech Metals launches IPO roadshow on NYSE at $16-$18 per share
• CalciMedica raises up to $49M in private placement for PH program
• Honeywell Aerospace to Join S&P 500 & S&P 100; Others to Join S&P MidCap 400 and S&P SmallCap 600